These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21719912)

  • 21. Intraoperative infrared brain surface blood flow monitoring during superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: clinical implication of the gradation value in postoperative clinical course--a case report.
    Nakagawa A; Fujimura M; Arafune T; Suzuki H; Sakuma I; Tominaga T
    Acta Neurochir Suppl; 2008; 102():159-63. PubMed ID: 19388309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristic Pattern of the Cerebral Hemodynamic Changes in the Acute Stage After Combined Revascularization Surgery for Adult Moyamoya Disease: N-isopropyl-p-[
    Fujimura M; Tominaga T
    Acta Neurochir Suppl; 2021; 132():57-61. PubMed ID: 33973029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous reddening as a possible sign of hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: case report.
    Machida T; Ono J; Nomura R; Fujikawa A; Nagano O; Higuchi Y
    Neurol Med Chir (Tokyo); 2014; 54(10):827-31. PubMed ID: 24670309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracranial Hemorrhage After Superficial Temporal Artery-Middle Cerebral Artery Direct Anastomosis for Adults with Moyamoya Disease.
    Park W; Park ES; Lee S; Park JC; Chung J; Lee JM; Ahn JS
    World Neurosurg; 2018 Nov; 119():e774-e782. PubMed ID: 30096496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
    Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
    Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.
    Sato K; Yamada M; Kuroda H; Yamamoto D; Asano Y; Inoue Y; Fujii K; Kumabe T
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1244-8. PubMed ID: 26939637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient Global Cerebral Hypoperfusion as a Characteristic Cerebral Hemodynamic Pattern in the Acute Stage after Combined Revascularization Surgery for Pediatric Moyamoya Disease: N-Isopropyl-P-[123I] Iodoamphetamine Single-Photon Emission Computed Tomography Study.
    Kanoke A; Fujimura M; Tashiro R; Ozaki D; Tominaga T
    Cerebrovasc Dis; 2022; 51(4):453-460. PubMed ID: 34933301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.
    Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T
    Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiopulmonary complication as a pitfall of the perioperative management of moyamoya syndrome with atherosclerosis: conflict to counteract with cerebral hyperperfusion].
    Sakata H; Fujimura M; Sato K; Shimizu H; Tominaga T
    No Shinkei Geka; 2014 Aug; 42(8):737-43. PubMed ID: 25087762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative platelet count may predict postoperative symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in moyamoya patients.
    Jo WY; Oh H; Kim H; Yoon HK; Lee HC; Cho WS; Kim JE; Park HP
    Clin Neurol Neurosurg; 2020 Dec; 199():106260. PubMed ID: 33031987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient crossed cerebellar diaschisis due to cerebral hyperperfusion following surgical revascularization for moyamoya disease: case report.
    Hokari M; Kuroda S; Simoda Y; Uchino H; Hirata K; Shiga T; Nakayama N; Houkin K; Tamaki N
    Neurol Med Chir (Tokyo); 2012; 52(5):350-3. PubMed ID: 22688075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A ruptured middle cerebral artery aneurysm originating from the site of anastomosis 20 years after extracranial-intracranial bypass for moyamoya disease: case report.
    Nishimoto T; Yuki K; Sasaki T; Murakami T; Kodama Y; Kurisu K
    Surg Neurol; 2005 Sep; 64(3):261-5; discussion 265. PubMed ID: 16099260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anastomosis of the superficial temporal artery to the middle cerebral artery with the interposed occipital artery graft in moyamoya disease: case report.
    Takeuchi S; Koike T; Tanaka R
    Surg Neurol; 1997 Dec; 48(6):615-9. PubMed ID: 9400645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease.
    Fujimura M; Kaneta T; Tominaga T
    Childs Nerv Syst; 2008 Jul; 24(7):827-32. PubMed ID: 18066556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative middle cerebral artery pressure measurements during superficial temporal artery to middle cerebral artery bypass procedures in patients with cerebral atherosclerotic disease.
    Matano F; Murai Y; Tanikawa R; Kamiyama H; Tateyama K; Tamaki T; Mizunari T; Mizumura S; Kobayashi S; Teramoto A; Morita A
    J Neurosurg; 2016 Dec; 125(6):1367-1373. PubMed ID: 26943849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease.
    Kaku Y; Iihara K; Nakajima N; Kataoka H; Fukuda K; Masuoka J; Fukushima K; Iida H; Hashimoto N
    J Cereb Blood Flow Metab; 2012 Nov; 32(11):2066-75. PubMed ID: 22850406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?
    Mukerji N; Cook DJ; Steinberg GK
    J Neurosurg; 2015 Jan; 122(1):90-4. PubMed ID: 25343178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease.
    Yanagihara W; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
    J Neurosurg; 2019 Dec; 131(6):1716-1724. PubMed ID: 30554180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.